Mobile

A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphatemic Chronic Kidney Disease Patients ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-003885-16

A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphatemic Chronic Kidney Disease Patients Not on Dialysis

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the efficacy and safety of sevelamer carbonate and placebo dosed three times a day (TID) on serum phosphorous levels.

Critère d'inclusion

  • Treatment of hyperphosphataemia

Liens